Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) was independently associated ...

In this randomized controlled trial of patients with nonrelapsing secondary progressive multiple sclerosis (SPMS), oral ...

In concurrent randomized controlled trials (GEMINI 1 and GEMINI 2) of patients with relapsing multiple sclerosis (RMS), ...

In this prospective cohort study, treatment with atidarsagene autotemce (arsa-cel) significantly reduced the risk of severe ...

In this randomized clinical trial, mixed reality exposure and response prevention (MERP) was a feasible treatment for ...

Intravenous hydrocortisone treatment was associated with reduced odds of new kidney replacement in patients with septic shock ...

Geriatric patients with ocular trauma had higher mortality rates within 5 years, particularly within the first year ...

In this randomized controlled trial, oral semaglutide significantly reduced the risk of adverse cardiovascular events in ...

In this randomized controlled trial (CHAPAS-4), tenofovir alafenamide fumarate (TAF) with emtricitabine showed superior viral ...

In this randomized controlled trial, oveporexton use significantly improved symptoms of narcolepsy over eight weeks. 2.

In this randomized controlled trial of patients with pulmonary arterial hypertension (PAH) and high risk of mortality, ...

Maximum walking distance at 52 weeks was significantly improved with semaglutide. 2. There were fewer treatment-related ...